Crystal Meth in Laval: Quebec’s Amphetamine and MDMA Trade

Crystal Meth in Laval: Quebec’s Amphetamine and MDMA Trade

Methamphetamine remains a potent drug threat. Laval, near Montreal, is situated in a major production region for illicit substances in tablet form, often involving Canadian-based Asian DTOs and OMGs. The province has a high lifetime usage rate (8.9%) for methamphetamine.

Regional Usage and Sourcing

• Usage Context:
**”Speed”** is the primary stimulant reported in Quebec treatment centres, but the market is closely linked to methamphetamine.
• Sourcing:
Methamphetamine tablets are primarily produced by Asian DTOs in **Quebec**, with some product intended for international markets.
• Drug Profile:
High levels of drug-related firearms offences have been reported in the province.

Severe Health and Social Consequences

Methamphetamine abuse creates severe harms, including a high risk of contracting infectious diseases.

• Physical Harms:
Meth use can cause heart attack, stroke, and sudden cardiac death, even in young users. Overdose symptoms include psychosis, rapid heart rate, and liver/kidney failure.
• Psychological Harms:
Users may experience psychosis, paranoia, violent behavior, and permanent brain damage.
• Community Impact:
Increased crime, including assault and property offenses, is associated with the erratic, aggressive, and paranoid state of methamphetamine users.

Legality and Penalties in Canada

Methamphetamine is classified as a Schedule I controlled substance under the federal Controlled Drugs and Substances Act (CDSA).

• Personal Possession (Indictable):
Maximum penalty is **seven years imprisonment**.
• Trafficking/Production (Indictable):
Maximum penalty is **life imprisonment**.
• First Offense (Summary Conviction):
May result in a fine up to $$1,000$ or imprisonment up to six months, or both.